Stoke Therapeutics Inc (STOK) is higher by Wednesday morning, with the stock increasing 3.69% in pre-market trading to 10.67. STOK's short-term technical score of 84 indicates that the stock has traded more bullishly over the last month than 84% of stocks on the market. In the Biotechnology industry, which ranks 100 out of 146 industries, Stoke Therapeutics Inc ranks higher than 90% of stocks. Stoke Therapeutics Inc has risen 73.23% over the past month, closing at $7.96 on February 28. During this period of time, the stock fell as low as $5.80 and as high as $8.58. STOK has an average analyst recommendation of Strong Buy. The company has an average price target of $19.86.
STOK has an Overall Score of 87. Find out what this means to you and get the rest of the rankings on STOK!